Search research articles
Contact Us
Filters
Showing results (61-70 of 78) with videos related to
Page
of 8
Sort By:
British Journal of Cancer
|
July 23, 2013
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
D H Moon, J-M Lee, A M Noonan, et al.
Blood
|
March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy
C J Link, A Bicher, E C Kohn, et al.
Biochemical and Biophysical Research Communications
|
June 30, 1988
Insulin-like growth factors stimulate chemotaxis in human melanoma cells
M L Stracke, E C Kohn, S A Aznavoorian, et al.
The Journal of Biological Chemistry
|
May 5, 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells
C P Minniti, E C Kohn, J H Grubb, et al.
Cancer
|
November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
J D Shapiro, M L Rothenberg, G A Sarosy, et al.
Journal of the National Cancer Institute
|
January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer
E C Kohn, G Sarosy, A Bicher, et al.
International Journal of Cancer
|
October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines
W J Wasilenko, A J Palad, K D Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations
E C Kohn, W D Figg, G A Sarosy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole
Y Wu, A J Palad, W J Wasilenko, et al.
Angiogenesis
|
October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)
K J Luzzi, H J Varghese, I C MacDonald, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 78) with videos related to
Sort By:
Page
of 8
British Journal of Cancer
|
July 23, 2013
Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactions
D H Moon, J-M Lee, A M Noonan, et al.
Blood
|
March 1, 1994
Flexible granulocyte colony-stimulating factor dosing in ovarian cancer patients who receive dose-intense taxol therapy
C J Link, A Bicher, E C Kohn, et al.
Biochemical and Biophysical Research Communications
|
June 30, 1988
Insulin-like growth factors stimulate chemotaxis in human melanoma cells
M L Stracke, E C Kohn, S A Aznavoorian, et al.
The Journal of Biological Chemistry
|
May 5, 1992
The insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor mediates IGF-II-induced motility in human rhabdomyosarcoma cells
C P Minniti, E C Kohn, J H Grubb, et al.
Cancer
|
November 7, 1998
Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer
J D Shapiro, M L Rothenberg, G A Sarosy, et al.
Journal of the National Cancer Institute
|
January 5, 1994
Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer
E C Kohn, G Sarosy, A Bicher, et al.
International Journal of Cancer
|
October 9, 1996
Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines
W J Wasilenko, A J Palad, K D Somers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1997
Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations
E C Kohn, W D Figg, G A Sarosy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 17, 1998
Inhibition of head and neck squamous cell carcinoma growth and invasion by the calcium influx inhibitor carboxyamido-triazole
Y Wu, A J Palad, W J Wasilenko, et al.
Angiogenesis
|
October 1, 2003
Inhibition of angiogenesis in liver metastases by carboxyamidotriazole (CAI)
K J Luzzi, H J Varghese, I C MacDonald, et al.
Page
of 8